# Biogen

Source: https://onco.cc/companies/da-biogen/  
OnCo record `da-biogen` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Biogen partnered on lecanemab and previously marketed aducanumab.

## Summary

Aducanumab’s withdrawn indication is recorded on the product page so history is not mistaken for a current option.

## Fields

- Kind: Company
- Last checked: 2026-09-21
- Tags: dementia-atlas
- HQ: Cambridge, MA
- Type: pharma
- Website: https://www.biogen.com/

## Sources

- Biogen: https://www.biogen.com/

## Connected records

- drugs: [Aducanumab](https://onco.cc/drugs/da-aducanumab/), [Lecanemab](https://onco.cc/drugs/da-lecanemab/)
- diagnoses: [Alzheimer’s disease](https://onco.cc/diagnoses/alzheimers-disease/)
- trials: [CLARITY AD](https://onco.cc/trials/da-trial-clarity-ad/), [ENGAGE](https://onco.cc/trials/da-trial-engage/)

---
JSON: https://onco.cc/api/v1/entities/da-biogen.json